1. Home
  2. SOHU vs ALT Comparison

SOHU vs ALT Comparison

Compare SOHU & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOHU
  • ALT
  • Stock Information
  • Founded
  • SOHU 1996
  • ALT 1997
  • Country
  • SOHU China
  • ALT United States
  • Employees
  • SOHU N/A
  • ALT N/A
  • Industry
  • SOHU EDP Services
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SOHU Technology
  • ALT Health Care
  • Exchange
  • SOHU Nasdaq
  • ALT Nasdaq
  • Market Cap
  • SOHU 319.0M
  • ALT 292.0M
  • IPO Year
  • SOHU 2000
  • ALT N/A
  • Fundamental
  • Price
  • SOHU $15.56
  • ALT $3.54
  • Analyst Decision
  • SOHU Strong Buy
  • ALT Strong Buy
  • Analyst Count
  • SOHU 1
  • ALT 6
  • Target Price
  • SOHU $20.00
  • ALT $17.40
  • AVG Volume (30 Days)
  • SOHU 79.2K
  • ALT 2.8M
  • Earning Date
  • SOHU 08-04-2025
  • ALT 08-12-2025
  • Dividend Yield
  • SOHU N/A
  • ALT N/A
  • EPS Growth
  • SOHU N/A
  • ALT N/A
  • EPS
  • SOHU 4.10
  • ALT N/A
  • Revenue
  • SOHU $548,588,000.00
  • ALT $20,000.00
  • Revenue This Year
  • SOHU N/A
  • ALT N/A
  • Revenue Next Year
  • SOHU $2.52
  • ALT $346,228.97
  • P/E Ratio
  • SOHU $3.78
  • ALT N/A
  • Revenue Growth
  • SOHU N/A
  • ALT N/A
  • 52 Week Low
  • SOHU $7.79
  • ALT $2.90
  • 52 Week High
  • SOHU $17.24
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • SOHU 56.71
  • ALT 39.37
  • Support Level
  • SOHU $14.82
  • ALT $3.51
  • Resistance Level
  • SOHU $15.96
  • ALT $3.78
  • Average True Range (ATR)
  • SOHU 0.59
  • ALT 0.18
  • MACD
  • SOHU -0.10
  • ALT 0.05
  • Stochastic Oscillator
  • SOHU 64.46
  • ALT 35.84

About SOHU Sohu.com Limited

Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. Sohu is an online media content and services provider. Through its social features, Sohu also enables users to generate and distribute content, as well as interact with each other on a platform. Changyou is an online game developer and operator. It generates maximum revenue from the Changyou segment.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: